Bone Disease

Approximately 23% of patients with chronic kidney disease meet the criteria for gout, of whom 13% have uncontrolled gout and 36% have no formal gout diagnosis, according to data published in Gout, Urate, and Crystal Deposition Disease.

Upacicalcet, an injectable calcimimetic, may be an effective and safe therapy for adults with secondary hyperparathyroidism on hemodialysis, according to a recently published study.

Adults with overweight or obesity had a 10% annual probability of achieving 5% or greater weight loss, according to study data published in JAMA Network Open.

SANTA FE, NEW MEXICO — In this video exclusive, Christopher Kovacs, MD, FRCP, FACP, FACE, talks about osteoporosis and fragility fractures associated with pregnancy and lactation.

The Healio Editors compiled news on osteoporosis in women’s health for National Women’s Health Week.

In a post from April about my struggle with osteoporosis, I wrote about my own case of the disease, which was unique in many ways.

Approximately one-quarter of adults with kidney stone disease had a diagnosis of osteoporosis or bone fracture at the time of their kidney stone diagnosis, according to a Veterans Affairs database analysis.

The FDA granted breakthrough device designation to a belt that uses proprietary vibration technology to stop the progression of bone loss and prevent the onset of osteoporosis, according to an industry press release.

Palovarotene reduced new heterotopic ossification volume in children and adults with fibrodysplasia ossificans progressiva, according to data from a phase 3 trial.

A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, are developing a synthetic antibody to SARS-CoV-2, the virus that causes COVID-19. This antibody is intended to block the virus from entering human lung cells, and, if successful in trials, could be a potential treatment option for patients infected with the novel coronavirus.